ZIVO Bioscience, Inc. announced the private placemen to issue 174,145 shares at an issue price of $3.05 per share for the gross proceeds of $531,142.25 on January 4, 2024. The transaction included participation from number of accredited investors. No solicitation was made and no underwriting discounts were given or paid in connection with this transaction.

The common stock was not registered under the Securities Act of 1933, as amended (the ?Securities Act?), or the securities laws of any state, and was offered and sold in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506) under the Securities Act and corresponding provisions of state securities laws, which exempts transactions by an issuer not involving any public offering. As of January 16, 2024, the Company has 2,748,167 common stock shares outstanding. The transaction is expected to close on January 16, 2024.